IP Library Granted Patent US 6,911,542
Granted Patent B2
US 6,911,542 · App. 10/297,682 · Granted Jun 28, 2005

Pyrazino[1′,2′:1,6]pyrido[3,4b]indole derivatives

Assignee: Lilly Icos LLC.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,911,542
App. No.
10/297,682
Granted
Jun 28, 2005
Kind
B2
Abstract

Compounds of the general structural formula (I) and use of the compounds and salts and solvates thereof, as therapeutic agents.

Claims (88)

1. A compound selected from the group consisting of

4-[2-((6R,12aR)-6-benzo[1,3]dioxol-5-yl- -1,4 -dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino-[1′,2′:1,6]-pyrido[3,4-b]indol-2-yl)ethyl]-benzenesulfonamide;

(6R,12aR)-6-benzo[1,3]dioxo-5-yl-2-hydroxy-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-methoxy-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-2-amino-6-benzo[1,3]dioxo-5-yl-1,2,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-methylamino-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]-pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-phenyl-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(2-dimethylaminoethyl)-3-methyl-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(+−,cis)-2-(2-dimethylamino-ethyl)-6-(4-methoxy-phenyl)-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(+−,cis)-6-benzo[1,3]dioxol-5-yl-2-(2-hydroxyethyl)-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(+−,cis)-2-(3-dimethylaminopropyl)-6-(4-methoxyphenyl)-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(+−,cis)-6-(4-methoxyphenyl)-2-[3-(4-methylpiperazin-1-yl)propyl]-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(+−,cis)-6-benzo[1,3]dioxol-5-yl-2-(2-piperidin-1-ylethyl)-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(+−,cis)-6-benzo[1,3]dioxol-5-yl-2-(-2-diethylaminoethyl)-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(+−,cis)-6-benzo[1,3]dioxol-5-yl-2-(2-morpholin-4-ylethyl)-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(2-morpholin-4-ylethyl)-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-(4-methoxyphenyl)-2-(2-morpholin-4-ylethyl)-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(3-morpholin-4-ylpropyl)-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(+−,cis)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino-[1′,2′:1,6]pyrido-[3,4-b]indole-2-yl)acetic acid methyl ester;

2-((+−,cis)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]pyrido[3,4-b]indol-2-yl)-acetamide;

(+−,cis)-2-(1-azabicyclo[2.2.2]oct-3-yl)-6-benzo[1,3]dioxol-5-yl-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(+−,cis)-6-benzo[1,3]dioxol-5-yl-2-(2-diisopropylaminoethyl)-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(+−,cis)-2-(1-azabicyclo[2.2.2]oct-3-yl)-6-benzo[1,3]dioxol-5-yl-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

3-((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]-pyrido[3,4-b]indol-2-yl)propionic acid ethyl ester;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(3-methoxypropyl)-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]-pyrido[3,4-b]indole-1,4-dione;

N-[2-((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]-pyrido[3,4-b]indol-2-yl)-ethyl]-acetamide;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-[3-(2-oxopyrrolidin-1-yl)propyl]-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

2-((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]-pyrido[3,4-b]indol-2-yl)-N-phenylacetamide;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(2-methoxyethyl)-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]-pyrido[3,4-b]indole-1,4-dione;

2-((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]-pyrido[3,4-b]indol-2-yl)-N-benzylacetamide;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(2-oxo-2-piperidin-1-ylethyl)-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(3-imidazol-1-ylpropyl)-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

3-((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]-pyrido[3,4-b]indol-2-yl)-N-cyclohexylpropionamide;

3-((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]-indol-2-yl)-N-butyl-N-methylpropionamide;

4-((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]-pyrido[3,4-b]indol-2-yl)-N-cyclohexylbutyramide;

3-((6R,12aS)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]-pyrido[3,4-b]indol-2-yl)propionic acid;

(+−,cis)-6-benzo[1,3]dioxol-5-yl-2-(tetrahydrofuran-2-ylmethyl)-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

2-((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]-pyrido[3,4-b]indol-2-yl)-N-pyridin-4-ylacetamide;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(3-ethoxypropyl)-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-[2-(2-hydroxyethoxy)ethyl]-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-((R)-2-hydroxypropyl)-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

2-((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]-pyrido[3,4-b]indol-2-yl)-N-methyl-N-phenylacetamide;

(+−,cis)-2-[2-(3-azabicyclo[3.2.2]non-3-yl)-ethyl]-6-benzo[1,3]dioxol-5-yl-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aS)-6-benzo[1,3]dioxol-5-yl-2-(1H-benzoimidazol-2-ylmethyl)-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-[2-(4-methylpiperazin-1-yl)ethyl]-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

4-((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-1H-pyrazino[1′,2′:1,6]pyrido[3,4-b]indole-2-ylmethyl)benzoic acid;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(4-dimethylaminobenzyl)-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(4-dimethylaminobenzyl)-3-methyl-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(+−,trans)-6-benzo[1,3]dioxol-5-yl-2-[2-((2R,6S)-2,6-dimethylmorpholin-4-yl)ethyl]-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(+−,cis)-6-benzo[1,3]dioxol-5-yl-2-[2-((2S,6R)-2,6-dimethylmorpholin-4-yl)ethyl]-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-2-[2-((2S,6R)-2,6-dimethyl-morpholin-4-yl)ethyl]-6-(4-methoxyphenyl)-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(2-imidazol-1-ylethyl)-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-[2-(2-methylimidazol-1-yl)ethyl]-2,3,6,7,12,12a-hexahydropyrazino[1′,21:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(2-imidazol-1-ylethyl)-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-2-(4-aminobenzyl)-6-benzo[1,3]-dioxol-5-yl-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

N-[4-((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-pyrazino[1′,2′:1,6]pyrido[3,4-b]indol-2-yl-methyl)phenyl]-1,1,1-trifluoromethanesulfonamide;

4-((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]-pyrido[3,4-b]indol-2-ylmethyl)-benzenesulfonamide;

4-((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]-pyrido[3,4-b]indol-2-ylmethyl)-benzonitrile;

(6-benzo[1,3]dioxol-4-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indol-2-yl)acetonitrile;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(1H-benzoimidazol-2-ylmethyl)-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

3-((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]-pyrido[3,4-b]indol-2-ylmethyl)-benzoic acid methyl ester;

(+−,cis)-6-benzo[1,3]dioxol-5-yl-2-[2-(1-methylpyrrolidin-2-yl)ethyl]-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-[2-(1H-imidazol-4-yl)ethyl]-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(4-dimethylaminomethylbenzyl)-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-2-[2-(4-aminophenyl)ethyl]-6-benzo[1,3]dioxol-5-yl-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]pyrido-[3,4-b]indol-2-yl)acetic acid benzyl ester;

((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]pyrido-[3,4-b]indol-2-yl)acetic acid;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-[3-(3,5-dimethylpyrazol-1-yl)propyl]-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

3-((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]-pyrido[3,4-b]indol-2-yl)propionic acid tert-butyl ester;

3-((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]-pyrido[3,4-b]indol-2-yl)propionic acid;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(3-dimethylaminomethylbenzyl)-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(2-pyrazol-1-ylethyl)-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(3-nitrobenzyl)-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-2-(3-aminobenzyl)-6-benzo[1,3]-dioxol-5-yl-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

N-[3-((6R,12aR)-6-benzo[1,3]dioxol-5-yl-4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]-pyrido[3,4-b]indole-2-ylmethyl)phenyl]-1,1,1-trifluoromethanesulfonamide;

(6R,12aR)-6-benzofuran-5-yl-2-(2-pyrazol-1-ylethyl)-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]-pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(3-pyrazol-1-ylpropyl)-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(4-benzyloxybenzyl)-2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-[4-(2-dimethylaminoethoxy)benzyl]-2,3,6,7,12,12a-hexahydropyrazino[1,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(2-[1,4,5]triazol-1-ylethyl)-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(4-methylamino-3-nitrobenzyl)-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

2-((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]-pyrido[3,4-b]indol-2-yl)-N-(4-methyl-piperazin-1-yl)acetamide;

(6R,12aR)-6-benzo[1,3]dioxol-5-yl-2-(1-methyl-1H-benzoimidazol-5-ylmethyl)-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione;

((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]pyrido-[3,4-b]indol-2-yl)acetic acid tert-butyl ester;

((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]pyrido-[3,4-b]indol-2-yl)acetic acid methyl ester;

((6R,12aR)-6-benzo[1,3]dioxol-5-yl-1,4-dioxo-3,4,6,7,12,12a-hexahydro-1H-pyrazino[1′,2′:1,6]pyrido-[3,4-b]indol-2-yl)acetic acid octyl ester;

and pharmaceutically acceptable salts and solvates thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2013
From: LILLY ICOS LLC
To: ICOS CORPORATION
Reel/Frame 031060/0250 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2003
From: ORME, MARK W.; SAWYER, JASON SCOTT; SCHULTZE, LISA M.; DAUGAN, ALAIN CLAUDE-MARIE; GELLIBERT, FRANCOISE
To: LILLY ICOS LLC
Reel/Frame 013989/0234 →
Continuity (2)
Provisional Application 6021364700 · Jun 23, 2000
Related Publication 20030225094A1 · Dec 4, 2003